Showing results (251-260 of 735) with videos related to
Sort By:
Pageof 74
Expert Opinion on Pharmacotherapy|May 22, 2010
Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorderAndrea Fagiolini, Francesco Casamassima, Wilmer Mostacciuolo, et al.Journal of Child and Adolescent Psychopharmacology|July 11, 2014
Clinical characteristics associated with lithium use among adolescents with bipolar disorderAthena Ko, Brenda Swampillai, Vanessa Timmins, et al.Journal of Andrology|July 14, 2001
Intracavernosal sildenafil facilitates penile erection independent of the nitric oxide pathwayI W McAuley, N N Kim, K Min, et al.Journal of Sex & Marital Therapy|September 14, 2001
Pharmacotherapy or psychotherapy?: effective treatment for FSD related to unresolved childhood sexual abuseL A Berman, J R Berman, D Bruck, et al.Psychosomatic Medicine|August 26, 1998
The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging StudyA B Araujo, R Durante, H A Feldman, et al.Obstetrics and Gynecology|October 1, 1994
Transabdominal needle embryofetoscopy: a new technique paving the way for early fetal therapyE A Reece, I Goldstein, A Chatwani, et al.The Journal of Urology|October 1, 1989
Regulation of adrenergic activity in penile corpus cavernosumI Saenz de Tejada, N Kim, I Lagan, et al.Urology|March 29, 2000
Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra)R Shabsigh, H Padma-Nathan, M Gittleman, et al.International Journal of Impotence Research|June 14, 2000
Cyclic AMP regulates mRNA expression of alpha-1d and alpha-2a adrenergic receptors in cultured human corpus cavernosum smooth muscle cellsA Traish, N N Kim, Y H Huang, et al.International Journal of Impotence Research|November 18, 2000
Axial penile rigidity as primary efficacy outcome during multi-institutional in-office dose titration clinical trials with alprostadil alfadex in patients with erectile dysfunction. Alprostadil Alfadex Study GroupI Goldstein, S Auerbach, H Padma-Nathan, et al.Pageof 74